Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DKUP06
|
|||
| Drug Name |
UB-312
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 1 | [1] | |
| Company |
United Neuroscience Ltd.
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04075318) A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UBITh? PD Immunotherapeutic Vaccine (UB-312) in Healthy Participants and Participants With Parkinson's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.